Literature DB >> 14709917

Lack of action potential-prolonging effect of terfenadine on rabbit myocardial tissue preparations.

Haruko Masumiya1, Mariko Saito, Mie Ito, Tomoyuki Matsuda, Kazuo Noguchi, Naoko Iida-Tanaka, Hikaru Tanaka, Koki Shigenobu.   

Abstract

The effects of terfenadine, an antiallergic drug also known for its QT-prolonging and arrhythmogenic activities, on the action potential of isolated myocardial tissue preparations from rabbits were examined with microelectrode techniques. In the Purkinje fibers and atrium, terfenadine concentration dependently decreased the maximum rate of rise (+.V(max)) without affecting other action potential parameters. In the ventricle, terfenadine had little effect on action potential configuration. In the sinoatrial node, terfenadine 20 microM prolonged cycle length mainly through inhibition of +.V(max). Terfenadine 1 microM completely inhibited the human ether a go-go-related gene (HERG) channel current expressed in HEK293 cells in the same experimental solution as in microelectrode experiments. The lack of terfenadine effect on the action potential duration suggests that there are drugs for which the HERG channel inhibitory action underlying in vivo QT prolongation cannot be evaluated based on their action potential-prolonging activity in isolated myocardial tissue preparations.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14709917     DOI: 10.1248/bpb.27.131

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  5 in total

1.  Does terfenadine-induced ventricular tachycardia/fibrillation directly relate to its QT prolongation and Torsades de Pointes?

Authors:  Hua Rong Lu; An N Hermans; David J Gallacher
Journal:  Br J Pharmacol       Date:  2012-06       Impact factor: 8.739

2.  Dog left ventricular midmyocardial myocytes for assessment of drug-induced delayed repolarization: short-term variability and proarrhythmic potential.

Authors:  Najah Abi-Gerges; Jean-Pierre Valentin; Chris E Pollard
Journal:  Br J Pharmacol       Date:  2009-08-06       Impact factor: 8.739

3.  Long-term bradycardia caused by atrioventricular block can remodel the canine heart to detect the histamine H1 blocker terfenadine-induced torsades de pointes arrhythmias.

Authors:  Akira Takahara; Atsushi Sugiyama; Yuko Ishida; Yoshioki Satoh; Kai Wang; Yuji Nakamura; Keitaro Hashimoto
Journal:  Br J Pharmacol       Date:  2006-03       Impact factor: 8.739

4.  Screening drug-induced arrhythmia [corrected] using human induced pluripotent stem cell-derived cardiomyocytes and low-impedance microelectrode arrays.

Authors:  Enrique G Navarrete; Ping Liang; Feng Lan; Verónica Sanchez-Freire; Chelsey Simmons; Tingyu Gong; Arun Sharma; Paul W Burridge; Bhagat Patlolla; Andrew S Lee; Haodi Wu; Ramin E Beygui; Sean M Wu; Robert C Robbins; Donald M Bers; Joseph C Wu
Journal:  Circulation       Date:  2013-09-10       Impact factor: 29.690

5.  On-chip spatiotemporal electrophysiological analysis of human stem cell derived cardiomyocytes enables quantitative assessment of proarrhythmia in drug development.

Authors:  Yumiko Asahi; Tomoyo Hamada; Akihiro Hattori; Kenji Matsuura; Masao Odaka; Fumimasa Nomura; Tomoyuki Kaneko; Yasuyuki Abe; Kiyoshi Takasuna; Atsushi Sanbuissho; Kenji Yasuda
Journal:  Sci Rep       Date:  2018-09-28       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.